PANEL DISCUSSION: Where are the Biggest Bottlenecks for Gene Therapy Immunogenicity & Which Approaches are Showing Most Promise (and Feasibility)?

Time: 2:30 pm
day: Post-Conference Discussion Day - Track A


  • Actively minimizing immunogenic responses
  • How close are we to redosing?
  • Widening patient eligibility in relation to antibody positivity
  • Exploring innovative vector modifications